XML 71 R56.htm IDEA: XBRL DOCUMENT v3.19.1
Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2019
Apr. 01, 2018
Segment Reporting Information [Line Items]    
Percentage Change In Sales By Geographic Area 0.10%  
Sales to customers (Note 9) $ 20,021 $ 20,009
Percentage Change in Operating Income Loss (19.30%)  
Earnings before provision for taxes on income $ 4,422 5,481
In-process research and development 890 0
Restructuring charges 36 42
Unrealized Gain (Loss) on Securities 100  
CONSUMER    
Segment Reporting Information [Line Items]    
Sales to customers (Note 9) 3,318 3,398
PHARMACEUTICAL    
Segment Reporting Information [Line Items]    
Sales to customers (Note 9) 10,244 9,844
Litigation expense 300  
Research and Development Expense 300  
Medical Devices    
Segment Reporting Information [Line Items]    
Sales to customers (Note 9) 6,459 6,767
Restructuring charges 100 100
Litigation expense 100  
Operating Segments    
Segment Reporting Information [Line Items]    
Total Segment Operating Income $ 4,569 5,793
Percentage Change in Operating Income Loss (21.10%)  
Operating Segments | CONSUMER    
Segment Reporting Information [Line Items]    
Total Segment Operating Income $ 741 548
Percentage Change in Operating Income Loss 35.20%  
Amortization $ 100 100
Operating Segments | PHARMACEUTICAL    
Segment Reporting Information [Line Items]    
Total Segment Operating Income $ 2,331 3,666
Percentage Change in Operating Income Loss (36.40%)  
Amortization $ 800 800
Operating Segments | Medical Devices    
Segment Reporting Information [Line Items]    
Total Segment Operating Income $ 1,497 1,579
Percentage Change in Operating Income Loss (5.20%)  
Amortization $ 200 300
Corporate, Non-Segment    
Segment Reporting Information [Line Items]    
Total Segment Operating Income 147 312
Ci:z Holdings Co. Ltd.    
Segment Reporting Information [Line Items]    
Gain on sale of equity investments $ 300  
Actelion | PHARMACEUTICAL    
Segment Reporting Information [Line Items]    
Acquisition related costs   100
United States    
Segment Reporting Information [Line Items]    
Percentage Change In Sales By Geographic Area 1.80%  
Sales to customers (Note 9) $ 10,129 9,951
United States | CONSUMER    
Segment Reporting Information [Line Items]    
Sales to customers (Note 9) 1,438 1,436
United States | PHARMACEUTICAL    
Segment Reporting Information [Line Items]    
Sales to customers (Note 9) 5,582 5,354
United States | Medical Devices    
Segment Reporting Information [Line Items]    
Sales to customers (Note 9) $ 3,109 3,161
Europe    
Segment Reporting Information [Line Items]    
Percentage Change In Sales By Geographic Area (3.90%)  
Sales to customers (Note 9) $ 4,609 4,797
Western Hemisphere, excluding U.S.    
Segment Reporting Information [Line Items]    
Percentage Change In Sales By Geographic Area (4.10%)  
Sales to customers (Note 9) $ 1,503 1,567
Asia-Pacific, Africa    
Segment Reporting Information [Line Items]    
Percentage Change In Sales By Geographic Area 2.30%  
Sales to customers (Note 9) $ 3,780 $ 3,694